Tyme Technologies

$1.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-2.54%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell TYME and other stocks, options, ETFs, and crypto commission-free!

About TYME

Tyme Technologies, Inc. Common Stock, also called Tyme Technologies, is a biotechnology company, which engages in the development and commercialization of cancer therapies. Read More It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in New York, NY.

Employees
15
Headquarters
New York, New York
Founded
2011
Market Cap
128.74M
Price-Earnings Ratio
Dividend Yield
Average Volume
392.74K
High Today
$1.21
Low Today
$1.15
Open Price
$1.16
Volume
203.38K
52 Week High
$4.64
52 Week Low
$0.92

Collections

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.